Comparative clinical study to evaluate the efficacy of vatsadanyadi kwatha and patoladi kwatha in the management of vatarakta with special reference to Gout.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Reduce the signs and symptoms of vatarakta
研究概览
简要总结
Primary Objective:
To compare the efficacy of Vatsadanyadi kwatha and Patoladi kwatha in Vatarakta with special reference to Gout.
Secondary Objectives:
-
To study the disease Vatarakta in Detail According to Ayurveda.
-
To Study Gout in Detail.
-
To Study the efficacy of Vatsadanyadi kwatha in Gout with special reference to Gout.
-
To Study the efficacy of Padoladi kwatha in Gout with special reference to Gout.
Participant
60 Adult diagnosed with vatarakta meeting inclusion and exclusion criteria from OPD and IPD of Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik
Interventions
30 patient Vatsadanyadi kwatha: administered according to standardized protocol.
30 patient Patoladi kwatha: administered according to standardized protocol.
Primary Outcomes:
Reduce signs and symptoms of Vatarakta
Secondary outcomes:
No recurrency of vatarakta
Treatment Duration: 30days
Follow up: 0th, 15th, 30th days
Data analysis:
Data will be analysed using appropriate statistical method to compare the effectiveness of the intervention on the primary and secondary outcomes
Ethical considerations:
The study will be conducted in accordance with ethical guidelines and with informed consent from participants
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients will be selected irrespective of their sex religion geographical areas and economical conditions Patients have fulfilling criteria for vatarakta such as Sandhishul a Sandhisotha Sandhigraha kandu Sandhidaha Age group 20 to 60 years Patients having uric acid level greater than 7 mg per dl in male and greater tha 6 mg per dl in female Newly diagnosed cases of vatarakta.
排除标准
- •1.Amavata (Rheumatoid Arthritis)
- •Sandhigatavata
- •With H/o Tuberculosis, malignancy, HIV, Trauma, Cardiac disease, Neurological disorders etc., associated with gout.
- •patient carring pregnancy and lactating mother.
- •5.patient having known complications of gout.
结局指标
主要结局
Reduce the signs and symptoms of vatarakta
时间窗: 15 days
次要结局
- No recurrence of vatarakta(30 days)
研究者
DrNisha Amrutrao Dhotre
Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik